These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9686554)

  • 21. Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
    de Boer SY; v d Meeberg PC; Siem H; de Boer WA
    Neth J Med; 2003 Jun; 61(6):218-22. PubMed ID: 12956102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of Helicobacter pylori serology after successful eradication.
    Cutler AF; Prasad VM
    Am J Gastroenterol; 1996 Jan; 91(1):85-8. PubMed ID: 8561150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of Helicobacter pylori infection in adults].
    Boixeda D
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
    [No Abstract]   [Full Text] [Related]  

  • 24. Accuracy of an enzyme immunoassay for the detection of Helicobacter pylori in stool specimens in the diagnosis of infection and posttreatment check-up.
    Forné M; Domínguez J; Fernández-Bañares F; Lite J; Esteve M; Galí N; Espinós JC; Quintana S; Viver JM
    Am J Gastroenterol; 2000 Sep; 95(9):2200-5. PubMed ID: 11007218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
    Kim MJ; Michener R; Triadafilopoulos G
    Gastroenterology; 1997 Jul; 113(1):31-7. PubMed ID: 9207259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study.
    Veldhuyzen Van Zanten S; Farley A; Marcon N; Lahaie R; Archambault A; Hunt R; Bailey R; Owen D; Spénard J; Stiglick A; Aimola N; Colin P
    Can J Gastroenterol; 2000; 14(7):599-602. PubMed ID: 10978947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-I in Helicobacter pylori gastritis and response to eradication using bismuth based triple therapy.
    Taha AS; Beastall G; Morton R; Park RH; Beattie AD
    J Clin Pathol; 1996 Aug; 49(8):676-8. PubMed ID: 8881922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
    Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
    Chen Q; Zhang W; Fu Q; Liang X; Liu W; Xiao S; Lu H
    Am J Gastroenterol; 2016 Dec; 111(12):1736-1742. PubMed ID: 27670603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
    Coyle WJ; Sedlack RE; Nemec R; Peterson R; Duntemann T; Murphy M; Lawson JM
    Am J Gastroenterol; 1999 Oct; 94(10):2885-9. PubMed ID: 10520838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic value of different methods applied for detecting Helicobacter pylori infection in gastric mucosa].
    Korzonek M
    Ann Acad Med Stetin; 1997; 43():143-59. PubMed ID: 9471913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection.
    de Boer WA
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):697-700. PubMed ID: 10445785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy.
    Lynch DA; Mapstone NP; Clarke AM; Sobala GM; Jackson P; Morrison L; Dixon MF; Quirke P; Axon AT
    Gut; 1995 Mar; 36(3):346-50. PubMed ID: 7698690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of Helicobacter pylori infection by specific gastric mucosal IgA and IgG pylori antibodies.
    Veenendaal RA; Götz JM; Schroijen V; Kurban F; Bernards AT; Veselic M; Peña AS; Lamers CB
    J Clin Pathol; 1995 Nov; 48(11):990-3. PubMed ID: 8543643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bismuth-based therapies for the first step eradication of Helicobacter pylori.
    Sezgin O; Altintaş E; Uçbilek E; Tataroğlu C
    Turk J Gastroenterol; 2006 Jun; 17(2):90-3. PubMed ID: 16830288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
    Gisbert JP; Boixeda D; Redondo C; Alvarez Baleriola I; Jiménez I; Pérez García JI; Pajares JM
    Rev Esp Enferm Dig; 1996 Apr; 88(4):259-64. PubMed ID: 9004796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
    Kato S; Takeyama J; Ebina K; Naganuma H
    Pediatrics; 1997 Jul; 100(1):E3. PubMed ID: 9200377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
    Liou JM; Fang YJ; Chen CC; Bair MJ; Chang CY; Lee YC; Chen MJ; Chen CC; Tseng CH; Hsu YC; Lee JY; Yang TH; Luo JC; Chang CC; Chen CY; Chen PY; Shun CT; Hsu WF; Hu WH; Chen YN; Sheu BS; Lin JT; Wu JY; El-Omar EM; Wu MS;
    Lancet; 2016 Nov; 388(10058):2355-2365. PubMed ID: 27769562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistance.
    Lerang F; Moum B; Ragnhildstveit E; Sandvei PK; Tolås P; Whist JE; Henriksen M; Haug JB; Berge T
    Am J Gastroenterol; 1998 Feb; 93(2):212-6. PubMed ID: 9468244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.
    Savarino V; Mela GS; Zentilin P; Lapertosa G; Bisso G; Mele MR; Pivari M; Mansi C; Vigneri S; Celle G
    Ital J Gastroenterol Hepatol; 1999; 31(1):4-8. PubMed ID: 10091096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.